Cargando…
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs †
Metabolic reprogramming represents a hallmark of tumorigenesis to sustain survival in harsh conditions, rapid growth and metastasis in order to resist to cancer therapies. These metabolic alterations involve glucose metabolism, known as the Warburg effect, increased glutaminolysis and enhanced amino...
Autores principales: | Chiarella, Emanuela, Nisticò, Clelia, Di Vito, Anna, Morrone, Helen Linda, Mesuraca, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138592/ https://www.ncbi.nlm.nih.gov/pubmed/35625883 http://dx.doi.org/10.3390/biomedicines10051146 |
Ejemplares similares
-
Editorial to the Special Issue “Recent Advances in Biochemical Mechanisms of Acute Myeloid Leukemia”
por: Mesuraca, Maria, et al.
Publicado: (2023) -
Isoprenoid biosynthesis regulation in poplars by methylerythritol phosphate and mevalonic acid pathways
por: Movahedi, Ali, et al.
Publicado: (2022) -
Five Questions about Non-Mevalonate Isoprenoid Biosynthesis
por: Odom, Audrey R.
Publicado: (2011) -
GAME9 regulates the biosynthesis of steroidal alkaloids and upstream isoprenoids in the plant mevalonate pathway
por: Cárdenas, Pablo D., et al.
Publicado: (2016) -
Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages
por: Munoz, Marcia A, et al.
Publicado: (2021)